Drugs / aMSC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01981330 | Jan 2012 → Feb 2020 | — | Karolinska University Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | aMSC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01981330 ↗ |
| Modality | Cell therapy | “autologous MSCs (0.5-2 × 106 MSCs/patient)” PMID 32197630 ↗ Mar 2020 |
| Route | Other | “aMSC injected into the vocal fold of the patient” NCT01981330 ↗ |